首页> 外文OA文献 >The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase.
【2h】

The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase.

机译:通过补体途径C5转化酶将人补体成分C5转化为片段C5b。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The cleavage of human complement component C5 to fragment C5b by the alternative pathway C5 convertase was studied. The alternative-pathway C5 convertase on zymosan can be represented by the empirical formula zymosan--C3b2BbP. Both properdin-stabilized C3 and C5 convertase activities decay with a half life of 34 min correlating with the loss of the Bb subunit. The C5 convertase functions in a stepwise fashion: first, C5 binds to C3b and this is followed by cleavage of C5 to C5b. The capacity to bind C3b is a stable feature of component C5, as C5b also has this binding capacity. Component C5, unlike component C3, does not form covalent bonds with zymosan after activation, and C5 is not inhibited by amines. Therefore C5, although similar in structure to C3, does not appear to contain the internal thioester group reported for C3 and C4.
机译:研究了通过替代途径C5转化酶将人补体组分C5切割成片段C5b。 zymosan上的替代途径C5转化酶可以用经验公式zymosan–C3b2BbP表示。备解素稳定的C3和C5转化酶活性都以34分钟的半衰期衰减,这与Bb亚基的丢失有关。 C5转化酶以逐步的方式起作用:首先,C5与C3b结合,然后将C5裂解为C5b。结合C3b的能力是组分C5的稳定特征,因为C5b也具有该结合能力。不同于组分C3,组分C5在活化后不与酵母聚糖形成共价键,并且C5不受胺的抑制。因此,C5尽管在结构上与C3相似,但似乎不包含针对C3和C4报道的内部硫酯基。

著录项

  • 作者

    DiScipio, R G;

  • 作者单位
  • 年度 1981
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号